0001209191-11-043960.txt : 20110812
0001209191-11-043960.hdr.sgml : 20110812
20110812144718
ACCESSION NUMBER: 0001209191-11-043960
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110811
FILED AS OF DATE: 20110812
DATE AS OF CHANGE: 20110812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carmine Bryce D.
CENTRAL INDEX KEY: 0001430788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 111030864
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LILLY ELI & CO
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1112
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1112
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-08-11
0
0000059478
LILLY ELI & CO
LLY
0001430788
Carmine Bryce D.
LILLY CORPORATE CENTER
INDIANAPOLIS
IN
46285
0
1
0
0
EVP and Pres, Lilly Bio-Meds
Common Stock
2011-08-11
4
S
0
5700
33.94
D
74298
D
Common Stock
6669
I
401(k)
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011.
This transaction was executed in multiple trades at prices ranging from $33.90 to $34.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
See attached footnotes page.
Bronwen Mantlo for Bryce D. Carmine, authorization on file
2011-08-12